Clinical Trials Logo
  1. Home
  2. Healthy Subjects
  3. NCT06076044
  4. Details
NCT06076044 Clinical Trial

Effects of Transcranial Oscillatory Direct Current Stimulation on the Functions of Cerebral Cortex in Healthy Subjects

Healthy Subjects Clinical Trial

Official title:
Effects of Transcranial Oscillatory Direct Current Stimulation on the Functions of Cerebral Cortex in Healthy Subjects

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT06076044
Other study ID # FirstHebei
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 1, 2023
Est. completion date March 15, 2024

Study information
Verified date February 2024
Source The First Hospital of Hebei Medical University
Contact Yuan Xing, PhD, MD
Phone +8618633888925
Email leaf_trunks@163.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To investigate the effect of transcranial oscillatory direct current stimulation on functions of cerebral cortex (cortical excitability and frequency of eeg) in healthy subjects

Recruitment information / eligibility
Status Recruiting
Enrollment 15
Est. completion date March 15, 2024
Est. primary completion date November 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 20 Years to 30 Years
Eligibility Inclusion Criteria: - Healthy male - Age ranges from 20 to 30 years old - No history of neurological or psychiatric diseases, no history of chronic illness - No positive results were found in the examination of the nervous system - All right-handed according to Edinburgh Handedness Inventory - The subjects voluntarily participated in this study and signed an informed consent form Exclusion Criteria: - Individuals with severe illnesses - Previous history of brain surgery or epilepsy - Individuals who experience changes in physical condition during the experiment - Individuals with metal implants, such as pacemakers, DBS therapists, stents, etc - Alcoholics

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• toDCS 2mA 1Hz
The subgroup treated by transcranial oscillatory direct current stimulation of 2mA and 1Hz.
• toDCS 2mA 10Hz
The subgroup treated by transcranial oscillatory direct current stimulation of 2mA and 10Hz.
• tDCS 1mA
The subgroup treated by transcranial direct current stimulation of 1mA.
• sham
The subgroup treated by sham stimulation.

Locations
Country Name City State
China the First Hospital of Hebei Medical University Shijiazhuang Hebei

Sponsors (1)
Lead Sponsor Collaborator
The First Hospital of Hebei Medical University

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary MEP Motor evoked potentials of the right abductor pollicis brevis were collected before treatment and 20, 30, 40, 50, 60 minutes after treatment
Primary Power Spectral Density of EEG The rest state EEG of the subjects was collected before treatment and right after treatment
See also
  Status Clinical Trial Phase
Completed NCT05483998 - A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants Phase 1
Recruiting NCT02417714 - Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
Recruiting NCT02235012 - Cognitive Biases Under Ketamine N/A
Completed NCT05088343 - Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects Phase 1
Completed NCT04418973 - Analysis of Breath Volatile Organic Compounds After Dyspnea Induced in the Healthy Subject. N/A
Not yet recruiting NCT06248801 - Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets Phase 1
Terminated NCT04068259 - Single Ascending Dose Study of PBI-4547 in Healthy Subjects Phase 1
Completed NCT03279302 - Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects Phase 1
Not yet recruiting NCT06233162 - Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets Phase 1
Recruiting NCT04159844 - Evaluation of the Stiffness and Pressure Applied on the Lower Leg by a New Compression Bandage on Healthy Subjects N/A
Completed NCT06137911 - Evaluation of Safety, Tolerability & Pharmacokinetics of JYP0061 in Healthy Adults. Phase 1
Completed NCT04849286 - Measurement of HTL0016878 in Cerebrospinal Fluid Phase 1
Not yet recruiting NCT06233227 - Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule Phase 1
Completed NCT04096157 - A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants Phase 1
Completed NCT01200368 - Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants Phase 3
Recruiting NCT05805033 - Peri-Implant Soft Tissue Integration in Humans: Influence of Material N/A
Completed NCT04027803 - Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris® Phase 1
Recruiting NCT03467880 - Multicenter Study of Impulse Oscillometry in Chinese N/A
Completed NCT02903095 - Single Ascending Dose Study of TD-1439 in Healthy Subjects Phase 1
Active, not recruiting NCT02341508 - A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers Phase 1